Your browser doesn't support javascript.
loading
A Tumor and Immune-Related Micro-RNA Signature Predicts Relapse-Free Survival of Melanoma Patients Treated with Ipilimumab.
Kobeissi, Iyad; Eljilany, Islam; Achkar, Tala; LaFramboise, William A; Santana-Santos, Lucas; Tarhini, Ahmad A.
  • Kobeissi I; Cutaneous Oncology and Immunology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
  • Eljilany I; Cutaneous Oncology and Immunology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
  • Achkar T; Hematology Department, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.
  • LaFramboise WA; Pathology and Laboratory Medicine Department, Allegheny Cancer Institute, Allegheny Health Network, Pittsburgh, PA 15524, USA.
  • Santana-Santos L; Pathology Department, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
  • Tarhini AA; Cutaneous Oncology and Immunology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
Int J Mol Sci ; 24(9)2023 May 03.
Article en En | MEDLINE | ID: mdl-37175874
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: MicroARNs / Melanoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: MicroARNs / Melanoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article